SERIES B PRE-FUNDED COMMON STOCK PURCHASE WARRANT KEMPHARM, INC.Series B Pre-Funded Common Stock Purchase Warrant • January 8th, 2021 • Kempharm, Inc • Pharmaceutical preparations • New York
THIS SERIES B PRE-FUNDED COMMON STOCK PURCHASE WARRANT (the “Warrant” and together with each other Series B Pre-Funded Common Stock Purchase Warrant, the “Warrants”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) until this Warrant is exercised in full (the “Termination Date”) but not thereafter, to subscribe for and purchase from KemPharm, Inc., a Delaware corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
